4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine

C108H209N21 — CID 159158383

IUPAC4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine
SMILESCCCCN(CCCC)c1nc(C)nc(N(CCCC)CCCC)n1.CCCCN(CCCC)c1nc(N(CCCC)CCCC)nc(N(CCCCCCN(C)C2CC(C)(C)CC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1.CCCCN(c1nc(C)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)CC(C)(C)C2)n1)C1CC(C)(C)NC(C)(C)C1
InChIInChI=1S/C45H88N8.C43H82N8.C20H39N5/c1-14-18-27-51(28-19-15-2)39-46-40(52(29-20-16-3)30-21-17-4)48-41(47-39)53(38-34-44(9,10)49-45(11,12)35-38)31-25-23-22-24-26-50(13)37-32-42(5,6)36-43(7,8)33-37;1-16-17-23-50(35-29-42(11,12)48-43(13,14)30-35)36-44-32(2)45-37(46-36)51(34-25-38(3,4)31-39(5,6)26-34)24-21-19-18-20-22-49(15)33-27-40(7,8)47-41(9,10)28-33;1-6-10-14-24(15-11-7-2)19-21-18(5)22-20(23-19)25(16-12-8-3)17-13-9-4/h37-38,49H,14-36H2,1-13H3;33-35,47-48H,16-31H2,1-15H3;6-17H2,1-5H3
InChIKeyKKEIBJZZWYGSGP-UHFFFAOYSA-N
MW1802.01 g/mol
LogP25.20
Rot. Bonds53

About 4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine

4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine (PubChem CID 159158383) has the molecular formula C108H209N21 and a molecular weight of 1802.01 g/mol. Its IUPAC name is 4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine.

Molecular Properties

Compound Name4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine
PubChem CID159158383
Molecular FormulaC108H209N21
Molecular Weight1802.01 g/mol
Exact Mass1800.70
IUPAC Name4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine
SMILESCCCCN(CCCC)c1nc(C)nc(N(CCCC)CCCC)n1.CCCCN(CCCC)c1nc(N(CCCC)CCCC)nc(N(CCCCCCN(C)C2CC(C)(C)CC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1.CCCCN(c1nc(C)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)CC(C)(C)C2)n1)C1CC(C)(C)NC(C)(C)C1
InChIInChI=1S/C45H88N8.C43H82N8.C20H39N5/c1-14-18-27-51(28-19-15-2)39-46-40(52(29-20-16-3)30-21-17-4)48-41(47-39)53(38-34-44(9,10)49-45(11,12)35-38)31-25-23-22-24-26-50(13)37-32-42(5,6)36-43(7,8)33-37;1-16-17-23-50(35-29-42(11,12)48-43(13,14)30-35)36-44-32(2)45-37(46-36)51(34-25-38(3,4)31-39(5,6)26-34)24-21-19-18-20-22-49(15)33-27-40(7,8)47-41(9,10)28-33;1-6-10-14-24(15-11-7-2)19-21-18(5)22-20(23-19)25(16-12-8-3)17-13-9-4/h37-38,49H,14-36H2,1-13H3;33-35,47-48H,16-31H2,1-15H3;6-17H2,1-5H3
InChIKeyKKEIBJZZWYGSGP-UHFFFAOYSA-N
XLogP25.20
TPSA181.26 Ų
H-Bond Donors3
H-Bond Acceptors21
Rotatable Bonds53
Heavy Atoms129
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001802.01
LogP ≤ 525.20
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1021

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine?
The IUPAC name of 4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine (CID 159158383) is 4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine.
What is the SMILES notation for 4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine?
The canonical SMILES for 4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine is CCCCN(CCCC)c1nc(C)nc(N(CCCC)CCCC)n1.CCCCN(CCCC)c1nc(N(CCCC)CCCC)nc(N(CCCCCCN(C)C2CC(C)(C)CC(C)(C)C2)C2CC(C)(C)NC(C)(C)C2)n1.CCCCN(c1nc(C)nc(N(CCCCCCN(C)C2CC(C)(C)NC(C)(C)C2)C2CC(C)(C)CC(C)(C)C2)n1)C1CC(C)(C)NC(C)(C)C1.
What is the InChIKey of 4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine?
The InChIKey is KKEIBJZZWYGSGP-UHFFFAOYSA-N. The full InChI is InChI=1S/C45H88N8.C43H82N8.C20H39N5/c1-14-18-27-51(28-19-15-2)39-46-40(52(29-20-16-3)30-21-17-4)48-41(47-39)53(38-34-44(9,10)49-45(11,12)35-38)31-25-23-22-24-26-50(13)37-32-42(5,6)36-43(7,8)33-37;1-16-17-23-50(35-29-42(11,12)48-43(13,14)30-35)36-44-32(2)45-37(46-36)51(34-25-38(3,4)31-39(5,6)26-34)24-21-19-18-20-22-49(15)33-27-40(7,8)47-41(9,10)28-33;1-6-10-14-24(15-11-7-2)19-21-18(5)22-20(23-19)25(16-12-8-3)17-13-9-4/h37-38,49H,14-36H2,1-13H3;33-35,47-48H,16-31H2,1-15H3;6-17H2,1-5H3.
What are the key properties of 4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine?
4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine has a molecular weight of 1802.01 g/mol, XLogP of 25.20, 53 rotatable bonds, 3 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 4-N-butyl-6-methyl-2-N-[6-[methyl-(2,2,6,6-tetramethylpiperidin-4-yl)amino]hexyl]-2-N-(3,3,5,5-tetramethylcyclohexyl)-4-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4-diamine;4-N,4-N,6-N,6-N-tetrabutyl-2-N-[6-[methyl-(3,3,5,5-tetramethylcyclohexyl)amino]hexyl]-2-N-(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine;2-N,2-N,4-N,4-N-tetrabutyl-6-methyl-1,3,5-triazine-2,4-diamine is sourced from PubChem (CID 159158383), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).